NewswireToday - /newswire/ -
Chicago, IL, United States, 2015/09/15 - The Product Development and Management Association (PDMA) announced that it has awarded the 2015 Outstanding Corporate Innovator (OCI) Award to BD (Becton, Dickinson and Company) - PDMA.org / BD.com. NYSE: BDX
The Product Development and Management Association (PDMA), the premier global advocate for product development and management professionals, announced today that it has awarded the 2015 Outstanding Corporate Innovator (OCI) Award to BD (Becton, Dickinson and Company).
BD’s focus on innovation has provided a framework to integrate the business, make acquisitions and coordinate actions vertically, from the top through operating levels of the company.
The OCI Award is the only innovation award which recognizes sustained (five or more years) and quantifiable business results from new products and services. Including BD, there have been 52 organizations to be granted the OCI Award over the course of its 25 year history. Past winners have included, DuPont, Merck, FedEx, Harley Davidson, Starbucks and Xerox.
BD will deliver a presentation on their sustained innovation success at the PDMA 2015 Annual Conference, being held Nov. 7-11 in Anaheim, Calif.
“The OCI Committee believes that the corporate commitment to innovation at BD, its new product development practices and its results are worthy of PDMA’s highest form of recognition,” said Suzanne Thompson, Chair, OCI Selection Committee and Vice President R&D, Growth Labs for Clorox. “We were particularly impressed with BD’s transformation journey to create more of an innovation culture, portfolio management and focus on ‘outside the home court’ and governance processes.”
“BD’s strategy is simply to apply technology and clinical knowledge to make healthcare more effective, efficient and safe; and our global innovation system is designed to support this strategy,” said Dr. Ellen Strahlman, Executive Vice President of Research & Development, and Chief Medical Officer at BD. “We are honored to receive this prestigious recognition that validates the relentless corporate commitment to innovation and the hard work of thousands of BD associates over many years in bringing new health innovations to the market. Our goal is to ensure that our innovations reach every patient around the world who needs them most, to save and improve their lives.”
The 2015 OCI Award will be presented to BD at the annual OCI Awards ceremony on Nov. 10 during the PDMA Annual Conference.
For more information about PDMA’s OCI Award, visit pdma.org/OCIaward.
The Product Development and Management Association (PDMA) is the premier global advocate for product development and management professionals. Its mission is to improve the effectiveness of individuals and organizations involved in the integrated activities related to all areas of product development and management.
PDMA (pdma.org) is the only organization that focuses on addressing this challenge by bringing together academics, professionals and solution providers in a community driven to accelerate the contribution innovation makes to the economic and professional growth of people, businesses and societies around the world.
BD (bd.com) is a leading medical technology company that partners with customers and stakeholders to address many of the world’s most pressing and evolving health needs. Our innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes. We are more than 45,000 associates in 50 countries who strive to fulfill our purpose of “Helping all people live healthy lives” by advancing the quality, accessibility, safety and affordability of healthcare around the world. In 2015, BD welcomed CareFusion and its products into the BD family of solutions.